These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 13763188)
1. The safety of beta-propiolactone as a biologic sterilizing agent. Clinical evaluation with human plasma and homotransplants. LOGRIPPO GA Angiology; 1961 Feb; 12():80-3. PubMed ID: 13763188 [No Abstract] [Full Text] [Related]
2. Serum hepatitis and the clinical evaluation of blood components sterilized with beta-propiolactone. LOGRIPPO GA Bibl Haematol; 1962; 13():504-9. PubMed ID: 14466320 [No Abstract] [Full Text] [Related]
7. The danger of serum hepatitis. RUYS AC Ned Tijdschr Geneeskd; 1959 Dec; 103():2537-8. PubMed ID: 14440393 [No Abstract] [Full Text] [Related]
8. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences. Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316 [TBL] [Abstract][Full Text] [Related]
9. [Problems in inoculation hepatitis. III. The possibilities of prevention]. LASZLO B Z Arztl Fortbild (Jena); 1956 Sep; 50(18):747-51. PubMed ID: 13393044 [No Abstract] [Full Text] [Related]
11. Safety of liquid plasma: a statistical appraisal. SAYMAN WA; GAULD RL; STAR SA; ALLEN JG J Am Med Assoc; 1958 Nov; 168(13):1735-9. PubMed ID: 13587253 [No Abstract] [Full Text] [Related]
12. Inactivation of the Hutchinson strain of hepatitis non-A, non-B virus in intravenous immunoglobulin by beta-propiolactone. Stephan W; Dichtelmüller H; Prince AM; Brotman B; Huima T J Med Virol; 1988 Nov; 26(3):227-32. PubMed ID: 3144576 [TBL] [Abstract][Full Text] [Related]
13. [Bilirubin increase in blood of normal subject]. DAVID F Praxis; 1952 May; 41(20):420. PubMed ID: 13003827 [No Abstract] [Full Text] [Related]
14. [On the problem of the use of beta-propiolactone in the sterilization of some labile biological preparations. (Preliminary communication)]. GEFEN NE; RUDNEVA OA; BAZHINOV AG Zh Mikrobiol Epidemiol Immunobiol; 1962 Mar; 33():103-8. PubMed ID: 13897488 [No Abstract] [Full Text] [Related]
15. Blood transfusions and serum hepatitis: use of monochloroacetate as an antibacterial agent in plasma. ALLEN JG; DAWSON D; SAYMAN WA; HUMPHREYS EM; BENHAM RS; HAVENS I Ann Surg; 1959 Sep; 150(3):455-68. PubMed ID: 13792752 [No Abstract] [Full Text] [Related]
16. Pooled plasma with little or no risk of homologous serum jaundice. ALLEN JG; ENERSON DM; BARRON ES J Am Med Assoc; 1954 Jan; 154(2):103-7. PubMed ID: 13108675 [No Abstract] [Full Text] [Related]
17. Serum hepatitis apparently acquired from irradiated plasma. ALBRECHT RM; KORNS RF; BEADENKOPF WG; GOODMAN MB; LOCKE FB; MARKS V J Am Med Assoc; 1953 Aug; 152(15):1423-6. PubMed ID: 13061292 [No Abstract] [Full Text] [Related]
18. Serum hepatitis from pooled irradiated dried plasma. MURPHY WP; WORKMAN WG J Am Med Assoc; 1953 Aug; 152(15):1421-3. PubMed ID: 13061291 [No Abstract] [Full Text] [Related]
19. [Prevention of dissemination of so-called homologous serum jaundice]. KEDRA M Przegl Lek; 1953; 9(2):40-2. PubMed ID: 13074320 [No Abstract] [Full Text] [Related]
20. Plasma transfusion without transmission of serum hepatitis. HOXWORTH PI; HAESLER WE J Am Med Assoc; 1958 Mar; 166(11):1291-3. PubMed ID: 13513354 [No Abstract] [Full Text] [Related] [Next] [New Search]